Australasian Melanoma Conference 2018

23:53

Curing Merkel cell carcinoma Progress and Challenges Shailender Bhatia

Curing Merkel cell carcinoma Progress and Challenges Shailender Bhatia
16:03

Immunotherapy for Recurrent or Metastatic Cutaneous SCC Danny Rischin

Immunotherapy for Recurrent or Metastatic Cutaneous SCC Danny Rischin
16:52

Hedgehog pathway inhibitors for BCC Pablo Fernandez-Penas

Hedgehog pathway inhibitors for BCC Pablo Fernandez-Penas
10:02

Ensuring the quality of melanoma care The National Melanoma Guidelines - the consumer perspective Alison Button-Sloan

Ensuring the quality of melanoma care The National Melanoma Guidelines - the consumer perspective Alison Button-Sloan
18:06

Ensuring the quality of melanoma care The National Melanoma Guidelines - the clinician perspective John Thompson

Ensuring the quality of melanoma care The National Melanoma Guidelines - the clinician perspective John Thompson
09:51

What it feels like for an understudied group of survivors- the survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors and combination BRAF and MEK inhibitors Julia Lai-Kwon

What it feels like for an understudied group of survivors- the survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors and combination BRAF and MEK inhibitors Julia Lai-Kwon
28:09

Treatment toxicity vs treatment benefit - what is the right balance Consumer Panel Discussion moderated by Grant McArthur

Treatment toxicity vs treatment benefit - what is the right balance Consumer Panel Discussion moderated by Grant McArthur

Join ArmchairMedical [Click here for more information]

Australasian Melanoma Conference 2018

Share with your friends

Curing Merkel cell carcinoma Progress and Challenges Shailender Bhatia

Immunotherapy for Recurrent or Metastatic Cutaneous SCC Danny Rischin

Hedgehog pathway inhibitors for BCC Pablo Fernandez-Penas

Ensuring the quality of melanoma care The National Melanoma Guidelines - the consumer perspective Alison Button-Sloan

Ensuring the quality of melanoma care The National Melanoma Guidelines - the clinician perspective John Thompson

What it feels like for an understudied group of survivors- the survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors and combination BRAF and MEK inhibitors Julia Lai-Kwon

Treatment toxicity vs treatment benefit - what is the right balance Consumer Panel Discussion moderated by Grant McArthur